Market Cap 12.02B
Revenue (ttm) 638.50M
Net Income (ttm) -183.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -28.69%
Debt to Equity Ratio 2.16
Volume 557,700
Avg Vol 725,586
Day's Range N/A - N/A
Shares Out 51.46M
Stochastic %K 67%
Beta 0.61
Analysts Strong Sell
Price Target $267.35

Company Profile

Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults; Sunosi (solriamfetol), a dopamine and norepinephrine reuptak...

Industry: Biotechnology
Sector: Healthcare
Phone: 212 332 3241
Fax: 212 320 0245
Address:
One World Trade Center, 29th Floor, New York, United States
Georgejj
Georgejj Jun. 5 at 2:45 AM
$AXSM Axsome Patent Deal Extends SUNOSI Clarity And Shapes Long Term Outlook https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/axsome-patent-deal-extends-sunosi-clarity-and-shapes-long-te Good luck and GOD bless,
0 · Reply
Vakeshka
Vakeshka Jun. 5 at 12:45 AM
$AXSM Geode Capital manages almost $2T investment portfolio - these folks see winners before rest of the crowd and put their money to work: "Geode Capital Management LLC lifted its position in shares of Axsome Therapeutics, Inc. by 1.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,010,249 shares of the company's stock after buying an additional 12,549 shares during the quarter. Geode Capital Management LLC owned about 2.00% of Axsome Therapeutics worth $184,544,000 at the end of the most recent reporting period..."
0 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Jun. 4 at 7:57 PM
$AXSM On a side note from the $5 share plunge the last few minutes of trading, AXSM announced they settled all patent related claims related to Sunosi (agreeing to certain dates generics can be sold). We'd remind investors ITCI announced it settled all patent related issues with Caplyta (agreeing to certain dates generics can be sold) 2 or 3 days before JNJ announced it was acquiring ITCI for a really big number. It is probably meaningless. This is not investment advice.
0 · Reply
pi22dv7
pi22dv7 Jun. 4 at 7:48 PM
$AXSM Did anyone did not like what was presented? 🤷‍♂️
0 · Reply
Georgejj
Georgejj Jun. 4 at 7:10 PM
$AXSM Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting https://finance.yahoo.com/sectors/healthcare/articles/axsome-therapeutics-presents-symbravo-data-110000973.html Good luck and GOD bless,
0 · Reply
pvll
pvll Jun. 4 at 2:49 PM
$AXSM look at my diamond hands!!
0 · Reply
1TimeDealer
1TimeDealer Jun. 4 at 2:20 PM
$CMPS was part of original sales force that launched Auvelity $AXSM anyone else notice that upper management that commercialized Auvelity is now at $CMPS ....just saying...
2 · Reply
Bio_investor_
Bio_investor_ Jun. 4 at 1:51 PM
$TGTX $AXSM $IBB $XBI We know AXSM can achieve much more than 10B some day but just for conservative if TG and AXSM gets anywhere from 3 to 5 billion peak sales, where would share price be.
2 · Reply
supplySHOCK
supplySHOCK Jun. 4 at 10:56 AM
0 · Reply
Northwinder
Northwinder Jun. 4 at 9:56 AM
$AXSM May we expect precscription numbers tomorrow to reflect initial numbers for Auvelity for ADA on top of MDD and if so, has anyone a gut feeling about what we may expect? As I understand it, the sales reps may already have booked some sales of the drug for ADA before the formal nod from FDA but maybe I am wrong.
3 · Reply
Latest News on AXSM
Axsome Therapeutics Recognizes Mental Health Month

May 7, 2026, 7:00 AM EDT - 4 weeks ago

Axsome Therapeutics Recognizes Mental Health Month


Axsome Therapeutics management to meet with Needham

2026-05-04T19:21:02.000Z - 4 weeks ago

Axsome Therapeutics management to meet with Needham


Axsome Therapeutics management to meet with Piper Sandler

2026-05-04T19:20:53.000Z - 4 weeks ago

Axsome Therapeutics management to meet with Piper Sandler


Axsome Therapeutics Earnings Call Transcript: Q1 2026

May 4, 2026, 8:00 AM EDT - 4 weeks ago

Axsome Therapeutics Earnings Call Transcript: Q1 2026


Axsome Therapeutics Earnings release: Q1 2026

May 4, 2026, 8:00 AM EDT - 4 weeks ago

Axsome Therapeutics Earnings release: Q1 2026


Axsome Therapeutics Slides: Q1 2026

May 4, 2026, 8:00 AM EDT - 4 weeks ago

Axsome Therapeutics Slides: Q1 2026


Axsome Therapeutics Quarterly report: Q1 2026

May 4, 2026, 8:00 AM EDT - 4 weeks ago

Axsome Therapeutics Quarterly report: Q1 2026


Axsome Therapeutics reports Q1 EPS ($1.26), consensus (86c)

2026-05-04T11:14:09.000Z - 4 weeks ago

Axsome Therapeutics reports Q1 EPS ($1.26), consensus (86c)


Axsome Therapeutics Transcript: FDA announcement

May 1, 2026, 8:00 AM EDT - 4 weeks ago

Axsome Therapeutics Transcript: FDA announcement


Axsome Therapeutics Press release: FDA announcement

May 1, 2026, 8:00 AM EDT - 4 weeks ago

Axsome Therapeutics Press release: FDA announcement


Axsome Therapeutics Slides: FDA announcement

May 1, 2026, 8:00 AM EDT - 4 weeks ago

Axsome Therapeutics Slides: FDA announcement


US FDA approves Axsome's drug for Alzheimer's-related agitation

Apr 30, 2026, 2:10 PM EDT - 5 weeks ago

US FDA approves Axsome's drug for Alzheimer's-related agitation


Axsome Therapeutics Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 5 weeks ago

Axsome Therapeutics Proxy statement: Proxy filing


Axsome Therapeutics Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 5 weeks ago

Axsome Therapeutics Proxy statement: Proxy filing


Axsome Therapeutics Earnings Call Transcript: Q4 2025

Feb 23, 2026, 8:00 AM EST - 3 months ago

Axsome Therapeutics Earnings Call Transcript: Q4 2025


Axsome Therapeutics Annual report: Q4 2025

Feb 23, 2026, 8:00 AM EST - 3 months ago

Axsome Therapeutics Annual report: Q4 2025


Axsome Therapeutics Earnings release: Q4 2025

Feb 23, 2026, 8:00 AM EST - 3 months ago

Axsome Therapeutics Earnings release: Q4 2025


Axsome Therapeutics Slides: Q4 2025

Feb 23, 2026, 8:00 AM EST - 3 months ago

Axsome Therapeutics Slides: Q4 2025


Axsome Therapeutics Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:00 AM EST - 7 months ago

Axsome Therapeutics Earnings Call Transcript: Q3 2025


Axsome Therapeutics Quarterly report: Q3 2025

Nov 3, 2025, 8:00 AM EST - 7 months ago

Axsome Therapeutics Quarterly report: Q3 2025


Axsome Therapeutics Earnings release: Q3 2025

Nov 3, 2025, 8:00 AM EST - 7 months ago

Axsome Therapeutics Earnings release: Q3 2025


Axsome Therapeutics Slides: Q3 2025

Nov 3, 2025, 8:00 AM EST - 7 months ago

Axsome Therapeutics Slides: Q3 2025


Axsome Therapeutics Earnings Call Transcript: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 10 months ago

Axsome Therapeutics Earnings Call Transcript: Q2 2025


Axsome Therapeutics Quarterly report: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 10 months ago

Axsome Therapeutics Quarterly report: Q2 2025


Axsome Therapeutics Earnings release: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 10 months ago

Axsome Therapeutics Earnings release: Q2 2025


Axsome Therapeutics Slides: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 10 months ago

Axsome Therapeutics Slides: Q2 2025


Axsome Therapeutics Transcript: R&D Day 2025

Jul 21, 2025, 11:00 AM EDT - 11 months ago

Axsome Therapeutics Transcript: R&D Day 2025


Axsome Therapeutics Slides: FY 2025

Jul 21, 2025, 11:00 AM EDT - 11 months ago

Axsome Therapeutics Slides: FY 2025


Axsome Therapeutics Earnings Call Transcript: Q1 2025

May 5, 2025, 8:00 AM EDT - 1 year ago

Axsome Therapeutics Earnings Call Transcript: Q1 2025


Axsome Therapeutics Quarterly report: Q1 2025

May 5, 2025, 8:00 AM EDT - 1 year ago

Axsome Therapeutics Quarterly report: Q1 2025


Axsome Therapeutics Earnings release: Q1 2025

May 5, 2025, 8:00 AM EDT - 1 year ago

Axsome Therapeutics Earnings release: Q1 2025


Axsome Therapeutics Slides: Q1 2025

May 5, 2025, 8:00 AM EDT - 1 year ago

Axsome Therapeutics Slides: Q1 2025


Axsome Therapeutics Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Axsome Therapeutics Proxy statement: Proxy Filing


Axsome Therapeutics Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Axsome Therapeutics Proxy statement: Proxy Filing


Axsome Therapeutics Earnings Call Transcript: Q4 2024

Feb 18, 2025, 8:00 AM EST - 1 year ago

Axsome Therapeutics Earnings Call Transcript: Q4 2024


Axsome Therapeutics Annual report: Q4 2024

Feb 18, 2025, 8:00 AM EST - 1 year ago

Axsome Therapeutics Annual report: Q4 2024


Axsome Therapeutics Earnings release: Q4 2024

Feb 18, 2025, 8:00 AM EST - 1 year ago

Axsome Therapeutics Earnings release: Q4 2024


Axsome Therapeutics Slides: Q4 2024

Feb 18, 2025, 8:00 AM EST - 1 year ago

Axsome Therapeutics Slides: Q4 2024


Axsome Therapeutics Transcript: FDA Announcement

Jan 31, 2025, 8:00 AM EST - 1 year ago

Axsome Therapeutics Transcript: FDA Announcement


Axsome Therapeutics Press release: FDA Announcement

Jan 31, 2025, 8:00 AM EST - 1 year ago

Axsome Therapeutics Press release: FDA Announcement


Axsome Therapeutics Slides: FDA Announcement

Jan 31, 2025, 8:00 AM EST - 1 year ago

Axsome Therapeutics Slides: FDA Announcement


US FDA approves Axsome Therapeutics' migraine drug

Jan 30, 2025, 3:55 PM EST - 1 year ago

US FDA approves Axsome Therapeutics' migraine drug


Axsome Therapeutics Transcript: Study Result

Dec 30, 2024, 8:00 AM EST - 1 year ago

Axsome Therapeutics Transcript: Study Result


Axsome Therapeutics Press release: Study Result

Dec 30, 2024, 8:00 AM EST - 1 year ago

Axsome Therapeutics Press release: Study Result


Axsome Therapeutics Slides: Study Result

Dec 30, 2024, 8:00 AM EST - 1 year ago

Axsome Therapeutics Slides: Study Result


Axsome Therapeutics Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Axsome Therapeutics Earnings Call Transcript: Q3 2024


Axsome Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Axsome Therapeutics Quarterly report: Q3 2024


Axsome Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Axsome Therapeutics Earnings release: Q3 2024


Axsome Therapeutics Slides: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Axsome Therapeutics Slides: Q3 2024


Axsome Therapeutics Earnings Call Transcript: Q2 2024

Aug 5, 2024, 8:00 AM EDT - 1 year ago

Axsome Therapeutics Earnings Call Transcript: Q2 2024


Axsome Therapeutics Quarterly report: Q2 2024

Aug 5, 2024, 8:00 AM EDT - 1 year ago

Axsome Therapeutics Quarterly report: Q2 2024


Axsome Therapeutics Earnings release: Q2 2024

Aug 5, 2024, 8:00 AM EDT - 1 year ago

Axsome Therapeutics Earnings release: Q2 2024


Axsome Therapeutics Transcript: AGM 2024

Jun 7, 2024, 9:00 AM EDT - 2 years ago

Axsome Therapeutics Transcript: AGM 2024


Georgejj
Georgejj Jun. 5 at 2:45 AM
$AXSM Axsome Patent Deal Extends SUNOSI Clarity And Shapes Long Term Outlook https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/axsome-patent-deal-extends-sunosi-clarity-and-shapes-long-te Good luck and GOD bless,
0 · Reply
Vakeshka
Vakeshka Jun. 5 at 12:45 AM
$AXSM Geode Capital manages almost $2T investment portfolio - these folks see winners before rest of the crowd and put their money to work: "Geode Capital Management LLC lifted its position in shares of Axsome Therapeutics, Inc. by 1.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,010,249 shares of the company's stock after buying an additional 12,549 shares during the quarter. Geode Capital Management LLC owned about 2.00% of Axsome Therapeutics worth $184,544,000 at the end of the most recent reporting period..."
0 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Jun. 4 at 7:57 PM
$AXSM On a side note from the $5 share plunge the last few minutes of trading, AXSM announced they settled all patent related claims related to Sunosi (agreeing to certain dates generics can be sold). We'd remind investors ITCI announced it settled all patent related issues with Caplyta (agreeing to certain dates generics can be sold) 2 or 3 days before JNJ announced it was acquiring ITCI for a really big number. It is probably meaningless. This is not investment advice.
0 · Reply
pi22dv7
pi22dv7 Jun. 4 at 7:48 PM
$AXSM Did anyone did not like what was presented? 🤷‍♂️
0 · Reply
Georgejj
Georgejj Jun. 4 at 7:10 PM
$AXSM Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting https://finance.yahoo.com/sectors/healthcare/articles/axsome-therapeutics-presents-symbravo-data-110000973.html Good luck and GOD bless,
0 · Reply
pvll
pvll Jun. 4 at 2:49 PM
$AXSM look at my diamond hands!!
0 · Reply
1TimeDealer
1TimeDealer Jun. 4 at 2:20 PM
$CMPS was part of original sales force that launched Auvelity $AXSM anyone else notice that upper management that commercialized Auvelity is now at $CMPS ....just saying...
2 · Reply
Bio_investor_
Bio_investor_ Jun. 4 at 1:51 PM
$TGTX $AXSM $IBB $XBI We know AXSM can achieve much more than 10B some day but just for conservative if TG and AXSM gets anywhere from 3 to 5 billion peak sales, where would share price be.
2 · Reply
supplySHOCK
supplySHOCK Jun. 4 at 10:56 AM
0 · Reply
Northwinder
Northwinder Jun. 4 at 9:56 AM
$AXSM May we expect precscription numbers tomorrow to reflect initial numbers for Auvelity for ADA on top of MDD and if so, has anyone a gut feeling about what we may expect? As I understand it, the sales reps may already have booked some sales of the drug for ADA before the formal nod from FDA but maybe I am wrong.
3 · Reply
supplySHOCK
supplySHOCK Jun. 4 at 9:40 AM
0 · Reply
supplySHOCK
supplySHOCK Jun. 4 at 8:05 AM
0 · Reply
Vakeshka
Vakeshka Jun. 4 at 1:18 AM
$AXSM smart money keeps buying. "BNP Paribas Financial Markets increased its position in shares of Axsome Therapeutics, Inc. by 60.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 304,388 shares of the company's stock after acquiring an additional 114,282 shares..owned approximately 0.60% of Axsome Therapeutics worth $55,593,000. Franklin Street Advisors Inc. NC acquired a new position valued at about $1,826,000. Aberdeen Group plc lifted its position by 15.5%. now owns 94,648 shares valued at $11,495,000 after buying an additional 12,732 shares. Pictet Asset Management Holding SA lifted its position by 20.4%..now owns 436,063 shares of the company's stock valued at $79,643,000 after buying an additional 73,925 shares. Finally, TD Asset Management Inc lifted its position in Axsome Therapeutics by 107.7%.. now owns 44,192 shares of the company's stock valued at $5,367,000 after buying an additional 22,914 shares.
0 · Reply
Mike826_1999
Mike826_1999 Jun. 4 at 12:30 AM
$AXSM Axsome filed new trademarks:
2 · Reply
Georgejj
Georgejj Jun. 3 at 11:45 PM
$AXSM https://www.auvelity.com/aad?gclsrc=aw.ds&gad_source=1&gad_campaignid=23773932365&gbraid=0AAAABDRKo_llt4mQGndRZrqDG4DEfQzWD&gclid=Cj0KCQjwof_QBhCgARIsADaMzOfAMcqBnw5RShW6TKEnPX5guHgwaCOMSC4EHg4bvHBVQdN3CLpckoMaApHUEALw_wcB
0 · Reply
Vakeshka
Vakeshka Jun. 3 at 11:40 PM
$AXSM William Blair conference - summary and full transcript: https://www.tradingview.com/symbols/NASDAQ-AXSM/documents/
0 · Reply
Georgejj
Georgejj Jun. 3 at 11:39 PM
$AXSM Why Axsome Therapeutics Stock Is Surging https://www.tipranks.com/news/catalyst/why-axsome-therapeutics-stock-is-surging-today-2#google_vignette Good luck and GOD bless,
0 · Reply
supplySHOCK
supplySHOCK Jun. 3 at 11:21 PM
0 · Reply
jlfromli
jlfromli Jun. 3 at 9:50 PM
$AXSM Zach’s uncovering The big movers. 😂 Why? Why, Down?
0 · Reply
chainma1l
chainma1l Jun. 3 at 9:30 PM
$AXSM green AF is the new red? Not off by a few pennies. Or a dollar. Or even TEN DOLLARS. Nostradamus has been closer than that.
0 · Reply
pvll
pvll Jun. 3 at 8:53 PM
$AXSM Diamond hands
0 · Reply
quickaspeter
quickaspeter Jun. 3 at 8:28 PM
$AXSM Oh baby..she’s a beauty!!! 💥🚀💰💰💰
1 · Reply